LLY

1,017.56

-3.18%↓

JNJ

248.4

-0.01%↓

ABBV

234.14

+0.93%↑

NVS

166.69

-0.97%↓

MRK

121.3

-1.96%↓

LLY

1,017.56

-3.18%↓

JNJ

248.4

-0.01%↓

ABBV

234.14

+0.93%↑

NVS

166.69

-0.97%↓

MRK

121.3

-1.96%↓

LLY

1,017.56

-3.18%↓

JNJ

248.4

-0.01%↓

ABBV

234.14

+0.93%↑

NVS

166.69

-0.97%↓

MRK

121.3

-1.96%↓

LLY

1,017.56

-3.18%↓

JNJ

248.4

-0.01%↓

ABBV

234.14

+0.93%↑

NVS

166.69

-0.97%↓

MRK

121.3

-1.96%↓

LLY

1,017.56

-3.18%↓

JNJ

248.4

-0.01%↓

ABBV

234.14

+0.93%↑

NVS

166.69

-0.97%↓

MRK

121.3

-1.96%↓

Home・Aandelen Lijst・Vivani Medical

Vivani Medical

Open

1.2 -0.83

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.2

Max

1.24

Belangrijke statistieken
By Trading Economics
Werknemers	37

Dividenden
By Dow Jones
Volgende Winsten	30 mrt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-19M 86M
Vorige openingsprijs	2.03
Vorige sluitingsprijs	1.2

Vivani Medical Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

1 mrt 2026, 23:35 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Prices Jump in Asia as U.S.-Iran Conflict Stokes Supply Fears -- Energy Comment

1 mrt 2026, 23:49 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Australian Gold-Mining Stocks Rally as Attack on Iran Drives Gold Higher -- Market Talk

1 mrt 2026, 23:47 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold, Silver Rise as Middle East Conflict Spurs Safe-Haven Demand -- Market Talk

1 mrt 2026, 23:41 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Lasting Oil Price Shock Could Stoke Global Inflation -- Market Talk

1 mrt 2026, 23:39 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Global Equities Roundup: Market Talk

1 mrt 2026, 23:39 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Nikkei May Fall Amid Concerns About Higher Energy Prices -- Market Talk

1 mrt 2026, 23:36 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Jumps as Middle East Conflict Heightens Supply Disruption Concerns -- Market Talk

1 mrt 2026, 23:24 UTC

Marktinformatie

Global Energy Roundup: Market Talk

1 mrt 2026, 23:24 UTC

Marktinformatie

Financial Markets Trim Bets on RBA Hike in May -- Market Talk

1 mrt 2026, 23:21 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

1 mrt 2026, 23:21 UTC

Marktinformatie

Sky Network TV's Risk/Reward Still Not Attractive -- Market Talk

1 mrt 2026, 23:19 UTC

Belangrijke Nieuwsgebeurtenissen

Front-Month Brent Crude Oil Futures Rose 8.5% to $79.08/bbl

1 mrt 2026, 23:17 UTC

Belangrijke Nieuwsgebeurtenissen

Front-Month WTI Crude Oil Futures Rose 8.4% to $72.65/bbl

1 mrt 2026, 23:14 UTC

Belangrijke Nieuwsgebeurtenissen

Front-Month WTI Crude Oil Futures Extend Gains in Early Trade

1 mrt 2026, 22:55 UTC

Belangrijke Nieuwsgebeurtenissen

Spot Gold Rises 1.9% to $5,278.61/oz Amid Middle East Conflict

1 mrt 2026, 22:54 UTC

Belangrijke Nieuwsgebeurtenissen

Front-Month WTI Crude Oil Futures Rise Amid Middle East Conflict

1 mrt 2026, 22:53 UTC

Belangrijke Nieuwsgebeurtenissen

Front-Month WTI Crude Oil Futures Rise 3.2% to $67.29/bbl

1 mrt 2026, 22:38 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Attack on Iran Likely to Push Up Floor Under Gold -- Market Talk

1 mrt 2026, 22:21 UTC

Winsten

Berkshire's Earnings Weren't as Bad as They Looked. A Goodwill Write-Down Hit Operating Profits. -- Barrons.com

1 mrt 2026, 22:17 UTC

Marktinformatie

Financial Markets Trim Bets On RBA Hike In May -- Market Talk

1 mrt 2026, 22:13 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

OPEC+ Oil Output Boost Could Be Moot if Strait of Hormuz Unavailable -- Market Talk

1 mrt 2026, 22:00 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Could Surge Above $100 If Flows Don't Return to Normal Quickly -- Market Talk

1 mrt 2026, 21:40 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Spot Gold Up as Investors Shield Against Risk -- Market Talk

1 mrt 2026, 21:35 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Prices Seen Rising to Low to Mid-US$80s Per Barrel -- Market Talk

1 mrt 2026, 21:30 UTC

Marktinformatie

Australian Dollar Weakens Most as Trader Fear Long-Term Conflict -- Market Talk

1 mrt 2026, 21:27 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Prices Likely to Rise on Iran Conflict But to Manageable Levels -- Market Talk

1 mrt 2026, 21:19 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Shipping Disruptions 'More Acute Risk' Than Oil Output From Iran Conflict -- Market Talk

1 mrt 2026, 20:58 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Risk Off Stance in Markets Amid Fears of Wider Conflict -- Market Talk

1 mrt 2026, 20:40 UTC

Marktinformatie

Australia Dollar to Fall Sharply Against U.S. Dollar on Middle East Conflict -- Market Talk

1 mrt 2026, 20:24 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Brent Crude at $100/bbl Could Slow Pace of Global Rate Cuts -- Market Talk

Peer Vergelijking

Prijswijziging

Vivani Medical Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

Buy

Hold

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan Vivani Medical - Dist in de afgelopen 3 maanden.

Financieel

Over Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.